ClinicaliQ Trial Snapshot
- Clinical Outcomes Study of the Nexel Total Elbow — Recruiting • Non-phase study • Infectious Disease • NCT02469662.
- Nexel Total Elbow implant study confirms it's safe and works well for new and repeat elbow replacement surgery.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement. Conditions: Elbow Joint Destruction, Post-traumatic Lesions, Ankylosed Joints, Advanced Rheumatoid Arthritis, Joint Instability or Loss of Motion, Acute Comminuted Articular Fracture of Elbow Joint Surfaces, Bone Loss Contributing to Elbow Instability, Bilateral Ankylosis From Causes Other Than Active Sepsis, Post-traumatic Arthritis, Degenerative Arthritis Interventions: Nexel Total Elbow Lead Sponsor: Zimmer Biomet Planned Enrollment: 134 participants